Vertex Pharmaceuticals Inc
Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –
Vertex Pharmaceuticals Alpine Immune Sciences by Quarter
Alpine Immune Sciences — Cash and cash equivalents ($M) ($M)
Vertex Pharmaceuticals Alpine Immune Sciences: $33.0M in Q1 2024, up 128.4% from a year earlier. No newer figure appears in the documents we track.
Where the Q1 2024 figure comes from
Source: SEC Filing ↗
Reported in SEC XBRL (CIK 0001626199 Alpine Immune Sciences).
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Alpine Immune Sciences — Cash and cash equivalents ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q1 2024 | Mar 31, 2024 | 33.0 | +128.4% | SEC Filing ↗ |
| Q4 2023 | Dec 31, 2023 | 43.9 | +228.3% | SEC Filing ↗ |
| Q3 2023 | Sep 30, 2023 | 19.0 | -85.0% | SEC Filing ↗ |
| Q2 2023 | Jun 30, 2023 | 34.1 | +39.9% | SEC Filing ↗ |
| Q1 2023 | Mar 31, 2023 | 14.5 | -58.6% | SEC Filing ↗ |
| Q4 2022 | Dec 31, 2022 | 13.4 | -80.3% | SEC Filing ↗ |
| Q3 2022 | Sep 30, 2022 | 127 | +66.4% | SEC Filing ↗ |
| Q2 2022 | Jun 30, 2022 | 24.4 | +29.5% | SEC Filing ↗ |
| Q1 2022 | Mar 31, 2022 | 34.9 | +176.2% | SEC Filing ↗ |
| Q4 2021 | Dec 31, 2021 | 67.9 | +94.3% | SEC Filing ↗ |
| Q3 2021 | Sep 30, 2021 | 76.1 | -46.1% | SEC Filing ↗ |
| Q2 2021 | Jun 30, 2021 | 18.8 | -78.7% | SEC Filing ↗ |
| Q1 2021 | Mar 31, 2021 | 12.6 | -48.3% | SEC Filing ↗ |
| Q4 2020 | Dec 31, 2020 | 35.0 | +116.9% | SEC Filing ↗ |
| Q3 2020 | Sep 30, 2020 | 141 | +711.2% | SEC Filing ↗ |
| Q2 2020 | Jun 30, 2020 | 88.2 | +470.3% | SEC Filing ↗ |
| Q1 2020 | Mar 31, 2020 | 24.5 | -41.0% | SEC Filing ↗ |
| Q4 2019 | Dec 31, 2019 | 16.1 | +50.5% | SEC Filing ↗ |
| Q3 2019 | Sep 30, 2019 | 17.4 | +51.6% | SEC Filing ↗ |
| Q2 2019 | Jun 30, 2019 | 15.5 | +333.3% | SEC Filing ↗ |
| Q1 2019 | Mar 31, 2019 | 41.4 | +456.2% | SEC Filing ↗ |
| Q4 2018 | Dec 31, 2018 | 10.7 | – | SEC Filing ↗ |
| Q3 2018 | Sep 30, 2018 | 11.5 | – | SEC Filing ↗ |
| Q2 2018 | Jun 30, 2018 | 3.57 | – | SEC Filing ↗ |
| Q1 2018 | Mar 31, 2018 | 7.45 | – | SEC Filing ↗ |
Cite this data
StockData. (2026). Vertex Pharmaceuticals Alpine Immune Sciences ($M), quarterly Q1 2018–Q1 2024 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/alpine-cash
See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.